GlassScriptPhysician profile
Nishit Patel
NPI 1831757145
$13,511.00
in general payments reported to CMS, 2019-2025
9 companies · $13K in 2025
The $13K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $249 · 2023: $383 · 2024: $64.52 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $13K · Food and Beverage: $762.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $12,500.00 |
| Food and Beverage | $761.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $12,899.48 | 2022-2025 | General - Therapies, Wallflex Duodenal, Compliance Endokit |
| Eisai INC. | $124.99 | 2025 | |
| Genzyme Corporation | $124.01 | 2023 | |
| Mallinckrodt Hospital Products INC. | $112.22 | 2025 | Terlivaz |
| E.R. Squibb & Sons, L.L.C. | $109.20 | 2023 | Zeposia |
| Abbvie INC. | $94.56 | 2022 | |
| Ardelyx, INC. | $20.10 | 2024 | Ibsrela |
| Janssen Biotech, INC. | $14.39 | 2023 | Stelara |
| Medtronic, INC. | $12.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nishit Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.